The mechanism underlying curcumin (diferuloylmethane) resistance is still largely unknown. Here we employed proteomic approach to identify the Siah-interacting protein (SIP) as a candidate for detailed study, because the spot intensity of SIP on a two-dimensional gel displayed 70-90% reduction in curcumin-sensitive cells, but remained unchanged in curcumin-resistant sublines, after curcumin treatment. Both gain-and loss-of-function studies revealed that SIP promoted curcumin-induced apoptosis. Moreover, SIP underwent phosphorylation and nuclear translocation in curcumin-sensitive but not resistant cells, upon curcumin exposure. The nuclear translocation of SIP was remarkably impaired when a putative nuclear localization sequence (NLS, amino acid (aa) 143-159) was deleted or the serine 141 was mutated into alanine, whereas truncation of the N-terminal region (aa 1-43) obviously increased the nuclear import of SIP. In accordance with their nuclear localization, N-terminal truncation significantly enhanced the proapoptotic effect of SIP, whereas NLS deletion or Ser141Ala mutation attenuated the apoptosis-promoting activity of both wildtype-and N-terminal truncated-SIP. These data suggest that SIP plays a role in apoptosis and curcumin resistance, and the function of SIP may be regulated by different motifs, such as the NLS, N-terminal region and serine 141. Our findings provide new insights into the biological significance of SIP and the mechanisms of drug resistance.
Introduction
Drug resistance is a major obstacle in cancer therapy and is responsible for high cancer mortality (O'Connor, 2009) . Dysfunction of apoptotic pathways has been implicated in drug resistance, and identification of molecules that regulate apoptosis is therefore essential for overcoming this global problem.
Curcumin (diferuloylmethane) is an active ingredient isolated from turmeric. Growing evidences indicate that curcumin is able to induce apoptosis in various cancer cells (Karunagaran et al., 2005) and to suppress tumorigenesis, angiogenesis and metastasis in diverse chemical-induced or xenograft tumor models (Kawamori et al., 1999; Li et al., 2002; Aggarwal et al., 2005; Bhandarkar and Arbiser, 2007) . Moreover, both phase I and phase II clinical trials show that curcumin is effective and well tolerated for cancer patients (Sharma et al., 2004; Dhillon et al., 2008) . To date, comprehensive studies have been conducted to characterize the anticancer effect of curcumin, but little is known about its resistance. In a previous study, we showed that Chk1-mediated G2/M arrest may serve as a mechanism for the resistance of hepatoma cells to curcumin-induced apoptosis (Wang et al., 2008) . Furthermore, our preliminary results revealed that curcumin could induce apoptosis in MOLT-4, a human lymphocytic leukemia cell line, and its 6-thioguanine (TG)-resistant subline (MOLT-4/TG), but not in its 9-b-D-arabinofuranosyl guanine (Ara-G)-resistant derivative (MOLT-4/AraG). To identify proteins involved in curcumin resistance, a proteomic approach was used to screen for differential proteins in MOLT-4 and its derivatives with and without curcumin treatment. As a result, the Siah-interacting protein (SIP) was identified as a candidate for detailed study, because spot intensity of SIP on a two-dimensional gel (2D-gel) obviously reduced in MOLT-4 and MOLT-4/TG, but not in MOLT-4/AraG after curcumin treatment.
The SIP protein, also named as Calcyclin binding protein, was originally identified in mouse brain as a binding protein of S100A6 (Calcyclin) (Filipek and Wojda, 1996) , whereas human homolog of SIP was discovered as a protein interacting with Siah (Matsuzawa and Reed, 2001) . It has been shown that SIP regulates the ubiquitination and degradation of b-catenin (Matsuzawa and Reed, 2001; Santelli et al., 2005) . Furthermore, SIP was downregulated in renal cell carcinoma tissues, and overexpression of SIP inhibited the ability of tumor cells to form colony in soft agar and to develop tumor in nude mice Sun et al., 2007) . These data suggest that SIP deregulation may contribute to cell proliferation and tumorigenesis. However, the role of SIP in apoptosis and in drug resistance is still unclear.
In this study, we reveal that SIP promotes curcumininduced apoptosis. Curcumin treatment results in phosphorylation and nuclear translocation of SIP in curcumin-sensitive but not in resistant cells. The Nterminal region, a nuclear localization sequence (NLS) and a potential phosphorylation site Ser141 are crucial for the nuclear import of SIP. Furthermore, defect in SIP nuclear translocation is associated with cell resistance to curcumin-and also to other stimuli-induced apoptosis. These results imply SIP as a regulator of apoptosis and drug resistance, and as a potential target for cancer therapy.
Results
The intensity change of SIP spot is different between curcumin-sensitive and -resistant cells upon curcumin treatment Our preliminary results showed that 25 mM curcumin was able to induce obvious apoptosis in MOLT-4 and MOLT-4/TG upon treatment for 24 h, whereas MOLT-4/AraG was extremely resistant to curcumin-induced apoptosis even at an extended exposure time of 48 h and at a high dose of 50 mM (Figure 1a , Supplementary Figure S1 and data not shown). To investigate the molecular basis of curcumin resistance, we compared the proteomes of curcumin-treated MOLT-4 and its derivative sublines (MOLT-4/TG and MOLT-4/AraG) with that of DMSO (vehicle control)-treated cells. The proteomes of DMSOtreated MOLT-4, MOLT-4/TG and MOLT-4/AraG cells were also compared. As a result, 332 spots with significant intensity differences (ratio X1.5, Po0.05) between either of the compared groups were revealed, and further MALDI-TOF mass spectroscopy analysis successfully identified 45 proteins from these spots (data not shown). Among them, the spot intensity of SIP (Supplementary  Table S1 ) on a 2D gel displayed 70-90% reduction in MOLT-4 and MOLT-4/TG, but remained almost the same in MOLT-4/AraG cells, after curcumin treatment (Figures 1b and c) . Furthermore, the spot intensity of SIP was higher in MOLT-4/AraG compared with MOLT-4 and MOLT-4/TG (Figures 1b and c) . These findings indicate that the intensity change of SIP spot may be related to the sensitivity of tumor cells to curcumininduced apoptosis. Therefore, the SIP protein was chosen for further investigation.
SIP displays distinct phosphorylation pattern and cellular localization in curcumin-sensitive and -resistant tumor cells To verify the above results, reverse transcription (RT)-PCR was initially employed and we found that curcumin exposure did not decrease the level of SIP mRNA in sensitive MOLT-4 and MOLT-4/TG cells (Figure 2a) , implying that SIP protein may be regulated at a post-transcriptional level upon curcumin treatment. Due to the lack of commercial antibody, we raised a polyclonal antiserum against SIP (anti-SIP), and demonstrated that it was suitable for immunoblotting, Figure 1 The intensity change of SIP spot is different between curcumin-sensitive and -resistant tumor cells upon curcumin treatment. (a) The sensitivity of MOLT-4 and its derivative lines to curcumin-induced apoptosis. Cells were treated with 25 mM curcumin for the indicated times, followed by apoptosis analysis using DAPI staining. (b) Representative 2D gel for MOLT-4 and its derivative lines. Cells were treated with DMSO or 25 mM curcumin (CUR) for 14 h, followed by 2D-gel analysis. Spot identified as SIP protein is indicated by arrows. (c) Semiquantitative measurement of the SIP protein spots from 2D gel. The intensity of each protein spot was determined, normalized to the sum of pixel intensities of all spots on the gel, and quantified as a percentage volume using ImageMaster 2D Platinum software 5.0. For (a) and (c), values represent the mean ± s.d. of three independent experiments. *Po0.05; **Po0.01; ***Po0.001.
Siah-interacting protein in apoptosis J Luo et al immunoprecipitation and immunostaining (Supplementary Figure S2 ). This anti-SIP was thereafter used for the detection of both exogenous and endogenous SIP protein. Interestingly, although immunoblotting analysis revealed a slight but reproducible reduction of SIP protein in both MOLT-4 and MOLT-4/TG after curcumin treatment and a higher level of SIP in MOLT-4/AraG than in MOLT-4 and MOLT-4/TG cells (Figure 2b) , the difference was much less evident than that on 2D gel (Figures 1b and c) . These data suggest that other modifications, besides the total amount of SIP protein, also contribute to the intensity change of SIP spot on 2D gel. It has been demonstrated that SIP is phosphorylated in unknown serine residues in neuroblastoma cells upon KCl or retinoic acid treatment (Filipek et al., 2002b; Wu et al., 2003) . Furthermore, phosphorylation may cause changes in both isoelectric point and molecular weight of protein and therefore lead to the relocation of protein spots on 2D gel. To verify whether the observed intensity change in SIP spot was due to the altered phosphorylation pattern of SIP, the whole cell extracts from MOLT-4 or MOLT-4/AraG treated with curcumin or DMSO were immunoprecipitated with anti-SIP, followed by immunoblotting with anti-phosphoserine antibody (Figure 2c ). Cells treated with PMA, a protein kinase C (PKC) activator proved to induce SIP phosphorylation (Filipek et al., 2002b) , served as a positive control. Interestingly, similar to PMA-treated cells, a strong band indicating phosphorylation in the serine residues of SIP was detected in curcumin-exposed MOLT-4 cells (Figure 2c , bottom left panel). In contrast, serine phosphorylation was found neither in curcumin-nor in PMA-treated MOLT-4/AraG cells (Figure 2c , bottom right panel), suggesting that the phosphorylation pattern of SIP is distinct in curcumin-sensitive (MOLT-4) and -resistant (MOLT-4/AraG) tumor cells, and the kinase(s) or other upstream factor(s), which are critical for SIP phosphorylation in response to either curcumin or PMA stimuli, may be deficient in MOLT-4/AraG. We further employed a human hepatoma cell line, HepG2, to verify the above observations. Curcumin treatment resulted in increased apoptosis and decreased SIP in HepG2 cells in a time-and dose-dependent manner (Figures 2d and e) . Significantly, enhanced phosphorylation in the serine residues of SIP was also detected in both curcumin-and PMA-exposed HepG2 cells (Figure 2f ), which was similar to that in MOLT-4 cells ( Figure 2c , left panel).
Collectively, these results suggest that curcumin treatment may result in increased phosphorylation of SIP in curcumin-sensitive but not resistant cells.
We next examined whether the cellular localization of SIP changed upon curcumin treatment, considering that it underwent both nuclear translocation and phosphorylation in KCl-or retinoic acid-treated cells (Filipek et al., 2002b; Wu et al., 2003) . Using immunofluorescence staining, we found that curcumin exposure caused a significant translocation of endogenous SIP from the cytoplasm to nucleus in both MOLT-4 and MOLT-4/TG but not in MOLT-4/AraG cells ( Figure 3a) . Furthermore, the staining of SIP was obviously stronger in MOLT-4/AraG than in MOLT-4 and MOLT-4/TG (Figure 3a) , which was consistent with the results from immunoblotting ( Figure 2b ). The translocation phenomenon was also observed in curcumin-treated HepG2 cells, in which SIP was initially detected in the cytoplasm and then translocated to the nucleus in a time-and dose-dependent manner ( Figure 3b ). Interestingly, similar to what we observed in MOLT-4/AraG cells (Figure 3a) , curcumin treatment could not affect the location of SIP in another hepatoma cell line Hep3B (data not shown), which was previously found to be resistant to curcumin-induced apoptosis (Wang et al., 2008) .
In summary, our results indicate that both phosphorylation and nuclear accumulation of SIP are crucial for curcumin-triggered apoptosis.
Nuclear translocation of SIP is regulated by different motifs As reported (Filipek et al., 2002a; Santelli et al., 2005) , the N-terminal amino acids (aa) 1-47 of SIP comprise a self-dimerization domain, and the C-terminal contains binding motifs for SKP1 and S100 proteins (Figure 4a ). To explore the mechanisms underlying nuclear translocation of SIP, the protein sequence of SIP was analyzed computationally. We predicted a region with putative NLS in aa 143-159 using PSORT II system (http:// psort.hgc.jp/form2.html; Nakai and Horton, 1999) , and a cluster of three potential phosphorylation sites (Ser137, Ser141 and Ser142) near the putative NLS using Disphos (http://www.ist.temple.edu/disphos; Iakoucheva et al., 2004) , NetPhos (http://www.cbs.dtu.dk/services/NetPhos; Blom et al., 1999) and KinasePhos (http://kinasephos. mbc.nctu.edu.tw; Huang et al., 2005) programs. Based on these pieces of evidence, a series of SIP mutants (Figures 4a and b) were constructed and their effects on the cellular localization of SIP were examined. The HepG2 cell line was employed for the following studies as it displayed similar phenotypes as MOLT-4 upon curcumin treatment and it demonstrated much higher transfection efficiency than MOLT-4. We found that transiently expressed EGFP-fused wild-type SIP (SIP-WT) was mainly present in the cytoplasm of HepG2 cells, whereas curcumin exposure obviously increased the proportion of cells with nuclear accumulation of SIP (Figure 4c and Supplementary Figure S3) , suggesting that both endogenous ( Figure 3 ) and exogenous SIP can translocate from the cytoplasm to nucleus in response to curcumin treatment. The nuclear translocation efficiency of the exogenously expressed mutant SIP was then assessed. Compared with SIP-WT, the Ser141Ala mutant (WT-S141A) and the NLS-deleted SIP (WT-ND) exhibited dramatic reduction in the nuclear translocation, whereas the WT-S137A and WT-S142A mutants revealed a similar rate of nuclear accumulation Siah-interacting protein in apoptosis J Luo et al ( Figure 4c and Supplementary Figure S3 ). These observations were further confirmed using wild-type and mutant SIP with His-tag instead of EGFP (Supplementary Figure S4 ). Notably, without curcumin treatment, nuclear localization of endogenous SIP was only observed in 2% HepG2 cells ( Figure 3b , the DMSOtreated group), whereas nuclear import of exogenous SIP-WTwas found in 24% cells (Figure 4c ), implying that a large amount of overexpressed SIP might promote its nuclear import. It is reported that there exists a transcription variant of hCacyBP/SIP (Iakoucheva et al., 2004) , which results in an isoform of SIP protein (hereafter named as SIP-S) that displayed truncation in the N-terminal aa 1-43 (GenBank accession no. NP_055227.1). Although we failed to detect the expression of SIP-S protein in our cell model with and without curcumin exposure (data not shown), it is worthwhile to investigate whether deletion of the aa 1-43 region could affect the nuclear translocation of SIP. EGFP-fused SIP-S construct and a series of SIP-S mutant were generated and transfected into HepG2 cells (Figures 4a and b) . Surprisingly, SIP-S underwent nuclear translocation spontaneously, independent of curcumin exposure, suggesting that the Nterminal region may be important for segregating SIP protein in cytoplasm (Figure 4c, Supplementary Figures  S3 and S4) . Consistent with the findings from wild-type SIP, S-ND and S-S141A mutants exhibited decreased nuclear accumulation, whereas S-S137A and S-S142A mutants showed a similar rate of nuclear localization, compared with SIP-S (Figure 4c and Supplementary Figure S3 ). HepG2 cells were transfected with plasmids expressing His-tagged wild-type or mutant SIP for 24 h, then exposed to 50 mM curcumin for 12 h, followed by immunoprecipitation (IP) using anti-His (His) and then western blotting (WB) using anti-His or anti-phosphoserine (p-Ser).
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To further validate the relationship between phosphorylation and nuclear import of SIP, we analyzed the phosphorylation patterns of SIP-WT, WT-S141A and WT-S142A, under DMSO or curcumin treatment (Figure 4d) . Compared with cells transfected with SIP-WT, WT-S141A but not WT-S142A transfectants displayed significantly less serine phosphorylation (Figure 4d) .
Collectively, these data suggest that the N-terminal, the NLS region and the phosphorylation of Ser141 residue are crucial in regulating the cellular localization of SIP.
Nuclear accumulation of SIP is associated with cell sensitivity to apoptosis To unravel the biological significance of nuclear accumulation of SIP, HepG2 cells transfected with EGFP (vector control), EGFP-fused wild type or mutant SIP were treated with DMSO or curcumin for 24 h. Apoptosis analysis by morphological examination revealed that compared with EGFP-transfected cells, SIP-WT transfectants displayed higher apoptotic rates with and without curcumin exposure (Figure 5a ), suggesting that SIP may have a proapoptotic function. Furthermore, the proapoptotic effect of SIP became more evident when the N-terminal aa 1-43 was deleted (SIP-S in Figure 5a ), which was in accordance with the increased nuclear accumulation of SIP-S. Interestingly, the NLS deletion and Ser141Ala mutation, which disturbed the nuclear translocation of SIP, dramatically attenuated the apoptosis-promoting effect of both SIP-WT and SIP-S (Figure 5a ). In contrast, Ser137Ala or Ser142Ala mutation, which had no impact on SIP translocation (Figure 4c ), could not affect the proapoptotic activity of SIP (data not shown). These results were reproducible in HepG2 cells exposed to different concentrations of curcumin for 12 h (Supplementary Figure S5) and were confirmed by terminal deoxynucleotidyl transferase-mediated 2 0 -deoxyuridine 5 0 -triphosphate nick end labeling (TUNEL) analysis, an alternative technique for apoptosis detection (Supplementary Figure S6 ). Taken together, our data indicate that defects in the nuclear translocation of SIP may contribute to curcumin resistance.
To further confirm the role of SIP in apoptosis, lossof-function analyses were performed using HepG2 cells that stably expressed the short-hairpin RNA (shRNA) targeting coding sequence (G2-659) or 3-untranslated region of SIP (G2-1170), or the scrambled control shRNA (G2-NC). For each shRNA, two stable clones were generated from independent retroviral infections (Supplementary Figure S7a) . Both G2-659 and G2-1170 cells displayed significantly lower apoptotic rates than G2-NC upon curcumin treatment (Figure 5b and Supplementary Figure S7b) , indicating that loss of SIP may inhibit curcumin-induced apoptosis in HepG2. The mitochondrial membrane potential (Dcm) was then examined using double staining with MitoTracker Deep Red FM (MTRed) and MitoTracker Green FM (MTGreen). In agreement with the apoptotic rates, curcumin-triggered loss of Dcm was abated in SIPknockdown cells compared with the control cells -659 and G2-1170) and its control cells (G2-NC) were treated with 35 mM curcumin for 12 h, then applied to apoptosis analysis using DAPI staining (b), and to detection of mitochondrial membrane potential (Dcm) using MTRed and MTGreen staining followed by flow cytometry analysis (c, d). The intensity of MTRed staining depends on Dcm, whereas the intensity of MTGreen remains the same regardless of Dcm and was thus used as an internal staining control. As for Dcm analysis, both bar chart (c) and representative dot plots (d) are shown. For (a-c), values represent the mean ± s.d. of three independent experiments. *Po0.05; **Po0.01; ***Po0.001.
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J Luo et al (Figures 5c and d, Supplementary Figures S7c and d) , implying that SIP may be involved in the mitochondrialmediated apoptosis.
To investigate whether the above observations were general phenomena in different cells with different stimuli-triggered apoptosis, the effect of Ser141Ala mutation was subsequently examined in HepG2 cells exposed to other apoptosis stimuli, including etoposide, doxorubicin, nitro-mustard, ultraviolet irradiation ( Figure 6 , left panels) and in another two human hepatoma cell lines (QGY-7703 and BEL-7404) treated with curcumin ( Figure 6 , right panels). Consistently, SIP-S displayed more pronounced nuclear accumulation and proapoptotic activity than SIP-WT, whereas Ser141Ala mutation significantly attenuated the effect of both SIP-WT and SIP-S (Figure 6 ). These results implicate that nuclear translocation of SIP, which is regulated at least partly by Ser141, may be involved in a common apoptotic signaling pathway.
Discussion
Results from others (Filipek et al., 2002b; Wu et al., 2003) and our studies suggest that phosphorylation and nuclear translocation are crucial for the function of SIP. We further demonstrate that phosphorylation at the Ser141 residue, the N-terminal region (aa 1-43) and the putative NLS region (aa 143-159) are crucial for nuclear translocation of SIP. These data are consistent with the contention that the nuclear import of most signaling proteins is NLS-dependent and is regulated by protein modifications, such as phosphorylation (Jans and Hubner, 1996; Lange et al., 2007) . Interestingly, although curcumin-resistant subline MOLT-4/AraG shows defect in both SIP phosphorylation and nuclear translocation, it contains an SIP-WT sequence identical to that in MOLT-4, according to our direct sequencing data (data not shown). These findings implicate that the kinases/upstream factors that regulate SIP phosphorylation may be deficient in MOLT-4/AraG.
It has been revealed that SIP is phosphorylated by PKC in vitro (Filipek et al., 2002b) and curcumin activates PKC in a membrane-dependent and calciumregulated manner (Mahmmoud, 2007) . In our study, both curcumin and PKC activator (PMA) cause SIP phosphorylation in MOLT-4 but not MOLT-4/AraG cells. Furthermore, NetPhosK (Blom et al., 2004) and KinasePhos (Huang et al., 2005) programs predict the Ser141 residue of SIP as the phosphorylation site of Figure 6 The Ser141Ala mutation attenuates the nuclear accumulation and the apoptosis-promoting effect of SIP in different cells treated with diverse apoptosis stimuli. The indicated cells were transfected with plasmids expressing EGFP-fused wild-type or mutant SIP for 24 h, incubated for 12 h with 25 mg/ml etoposide (ETO), 500 ng/ml doxorubicin (DOXO), 25 mM nitro mustard (NM), 100 J/m PKC. The role of PKC in the apoptosis signaling pathway is contradictory and depends on the isozyme and cell context (Gutcher et al., 2003) . For example, PKCe-deficient thyroid cells display reduced sensitivity to apoptosis induced by DNA-damaging agents, including actinomycin D, ultraviolet irradiation and doxorubicin (Knauf et al., 1999) , whereas overexpression of PKCe in MCF-7 cells downregulates p53 and inhibits TRAIL-induced apoptosis (Shankar et al., 2008) . In addition to PKC, KinasePhos also predicts Cdk1 as the potential kinase for Ser141 phosphorylation. Interestingly, our previous study shows that curcumin treatment results in Cdk1 inactivation in curcumin-resistant but not -sensitive cells (Wang et al., 2008) . Therefore, the effect of PKC and Cdk1 in SIP-mediated apoptosis is worth to be explored in the future.
Notably, both theoretical estimation and immunoblotting analysis reveal that the molecular weight of SIP is around 30 kDa. As we know, small proteins (MW o40 kDa) may, in principle, diffuse passively through the nuclear pores (Lange et al., 2007) . However, it has been shown that SIP can self-dimerize through the N-terminal aa 1-47 (Santelli et al., 2005) . In that case, the resulting protein dimer may become too large to diffuse passively into the nucleus. On the other hand, the nuclear import of the exogenously expressed SIP-S protein, which has the truncation of N-terminal aa 1-43 within the self-dimerization domain, is significantly attenuated when its NLS is deleted or Ser141 is substituted with alanine. These data indicate that the nuclear transport of SIP is applied to precise regulation rather than passive diffusion. The above results also emphasize that the NLS domain and the Ser141 residue, as well as the N-terminal region, have important roles in cellular translocation of SIP and may have further impact on SIP-mediated apoptotic signaling.
The significant correlation between nuclear accumulation of SIP and its proapoptotic activity further implicate that the nuclear import of SIP is an important step rather than an accompanying phenomenon during the apoptosis process, and impaired translocation of SIP may render cells resistant to apoptotic stimuli. Interestingly, we also notice that the apoptotic rates are similar between SIP-WT-and WT-S141A-transfected HepG2 cells treated with etoposide or in BEL-7404 cells exposed to curcumin (Figure 6) , although SIP-WT shows much higher nuclear translocation efficiency than WT-S141A. These discrepancies are likely due to the difference in cell context and the types of stimuli. Yang et al. (2006) report that antisense oligonucleotides against SIP significantly inhibit apoptosis in endometrial stromal cells 12 h after ultraviolet irradiation. Consistently, SIP knockdown by RNAi attenuates apoptosis triggered by curcumin at the 12-h time point. Intriguingly, the apoptotic rates of SIP-knockdown cells increase to a similar level as those of control cells at 24 h and become even higher than control cells at 48 h after curcumin exposure (data not shown). These data may suggest that SIP has an important role in the initiation step of curcumin-induced apoptosis, whereas inhibition of SIP signaling may activate an SIP-independent apoptotic pathway.
Although little is known about the mechanism of SIPmediated apoptotic signaling, some insights may be obtained from previous studies on proteins interacting with SIP. It has been shown that S100 family members interact with the C-terminal region of SIP (Filipek et al., 2002a; Bhattacharya et al., 2005) and some of the members, such as S100A1, S100A2, S100A6 and S100B, are involved in apoptosis regulation, and many S100 proteins display cellular translocation in response to various stimuli (Hsieh et al., 2002; Orre et al., 2007; Joo et al., 2008) . Besides, SIP has been found to interact with ERK1/2 and downregulate ERK activity (Kilanczyk et al., 2009) . Furthermore, suppression of the ERK-involved pathway sensitizes cancer cells to apoptosis (Tran et al., 2001; Wu et al., 2004) and a series of inhibitors targeting ERK pathway have been identified as potential anti-cancer drugs (Daouti et al., 2009) . It has also been shown that SIP serves as a molecular bridge between Siah-1 and Skp1 proteins, and forms a ubiquitin ligase complex together with Ebi and in turn promotes b-catenin degradation. b-Catenin is a widely studied oncogene and is able to impel the transcription of regulators of cell proliferation and apoptosis, such as cyclin D1, c-Myc and survivin (Jin et al., 2008; Takigawa and Brown, 2008) . Taken together, we speculate that SIP may exert its function on apoptotic signaling by interacting with other proteins. Further efforts to identify these proteins and their function in SIP-mediated apoptotic signaling are surely warranted.
In summary, we investigate the role of SIP in apoptotic signaling and its underlying mechanisms, and reveal that defects in SIP phosphorylation and nuclear translocation may contribute to the reduced cell sensitivity to apoptosis stimuli. Our data provide new insights into the biological function of SIP protein and the potential mechanisms of curcumin resistance.
Materials and methods
Detailed description on the reagents and experimental procedures can be found in the Supplementary Methods.
Cell lines
MOLT-4/TG and MOLT-4/AraG (generous gifts from Dr Curt Peterson, Linko¨ping University, Linko¨ping, Sweden) were derived from human acute lymphocytic leukemia cell lines MOLT-4 by long-time exposure to low doses of TG and Ara-G, respectively (Lotfi et al., 2002; Mansson et al., 2002) . The IC 50 values of TG and Ara-G for these cell lines are shown in Supplementary Table S2 .
Stable SIP-knockdown HepG2 cell lines (G2-659 and G2-1170) and their control line (G2-NC) were generated using retroviral vectors pSR-puro-sh659, pSR-puro-sh1170 and pSR-puro-NC, respectively.
MOLT-4 and its derivatives were grown in RPMI 1640 (Gibco Invitrogen, Carlsbad, CA, USA), and human hepatoma cell lines (HepG2, Hep3B, QGY-7703 and BEL-7404) were grown in DMEM (Gibco Invitrogen), supplemented with 10% FBS (PAA, Haidmannweg, Austria) and 2 mM L-glutamine (Sigma, St Louis, MO, USA).
Plasmids, siRNA duplexes and cell transfection All primer sequences used for plasmid construction and siRNA sequences are shown in Supplementary Table S3 .
The plasmids used in this study included the following. The prokaryotic expression vector pET-28b-SIP that expressed a His-tagged SIP was used to immunize rabbits and produce anti-SIP; p3FH-SIP that expressed Flag-and HA-tagged SIP was used to verify the effectiveness of anti-SIP in immunoblotting and immunoprecipitation; the eukaryotic expression vectors of His or EGFP-tagged SIP and its mutant forms, constructed based on pcDNA3.0 (Invitrogen, Seattle, WA, USA), were used to analyze the SIP cellular localization and their effect on apoptosis; the pSR-puro-sh659 and pSR-purosh1170 that expressed shRNA were used to target the coding sequence (659-677 nt, NM_014412.2) and the 3-untranslated region (1170-1188 nt) of SIP, respectively; the pSR-puro-NC vector, a generous gift from Dr Zeng MS (Cancer Center, Sun Yat-sen University, Guangzhou, PR China), expressed the scrambled shRNA and was used as a negative control.
Lipofectamine and PLUS reagent (Invitrogen) were used for plasmid transfection and Lipofectamine RNAiMAX (Invitrogen) for the transfection of siRNA duplex.
Preparation of antisera against human SIP protein
To generate rabbit polyclonal antisera against SIP, the Histagged SIP protein was expressed in Escherichia coli strain BL21 (Novagen, Madison, WI, USA) using pET-28b-SIP, then purified with HisBind Purification Kits (Novagen) and applied to immunize rabbits. The male white New Zealand rabbit was injected with 1 mg His-tagged SIP protein emulsified with complete Freund's adjuvant (Sigma). Three booster injections with 500, 250 and 125 mg protein emulsified with incomplete Freund's adjuvant (Sigma) were then conducted at 2-week intervals. Antisera were collected 1 week after the last immunization.
Detection of apoptosis
Apoptosis was evaluated by morphological examination using DAPI or PI staining, by flow cytometry analysis using Annexin V-PI staining, and by TUNEL assay using DeadEnd Fluorometric TUNEL System (Promega, Madison, WI, USA).
Two-dimensional gel electrophoresis-based comparative proteomics
For comparative proteomic analysis, cells were treated with DMSO or 25 mM curcumin for 14 h. Proteins (600 mg) were applied to 24 cm Immobiline Drystrip (pH 3-10, linear gradient; Amersham, GE Healthcare, Uppsala, Sweden) for the first dimensional isoelectric focusing, and then separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using EttanTM DALTsix system (Amersham). Gels from three independent experiments were analyzed using ImageMaster 2D Platinum software 5.0 (Amersham). Only spots that showed significant and reproducible changes in the intensity (ratio X1.5, Po0.05) were selected for protein identification. Peptide mass fingerprint of protein was obtained using Ettan MALDI-TOF Pro (Amersham). Proteins were identified by searching in the publicly available database NCBInr or SWISS-PROT using Profound search engine (Amersham).
Western blotting and immunoprecipitation
For western blotting, proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8-15%), electrophoretically transferred to 0.22 mm Immobilon-P PVDF membranes (Millipore, Billerica, MA, USA), and detected by specific antibodies and an ECL kit (Pierce, Rockford, IL, USA).
For immunoprecipitation assay, cells were lysed in protein extraction buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 8 mM MgCl 2 and 1% NP-40) containing Complete Mini EDTA-free protease inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail (Roche, Mannheim, Germany). Extracts were incubated with anti-HA or anti-SIP and protein A/G plus beads at 4 1C for 2 h. After three washes with buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl and 0.1% NP-40, the immune complexes were applied to immunoblotting.
RNA extraction and semiquantitative RT-PCR Total RNA from cells was extracted using Trizol (Invitrogen). To obtain cDNA, 2 mg of total RNAs was reversely transcribed using Moloney murine leukemia virus reverse transcriptase (Promega). Specific primers used for RT-PCR are listed in Supplementary Table S3 .
Analysis of subcellular localization of SIP To detect endogenous SIP or exogenous His-tagged SIP, immunostaining was performed as reported (Wang et al., 2008) , using anti-SIP or anti-His as primary antibody and goat-anti-rabbit or mouse Alexa-488 conjugated secondary antibody. The nucleus was counterstained with DAPI or PI. All images were captured under a fluorescence microscope. Cells with green fluorescence in nucleus were defined as nuclear localization of SIP.
Measurement of mitochondrial membrane potential
Cells were stained with both MitoTracker Deep Red FM and MitoTracker Green FM (Invitrogen) at 37 1C for 20 min in the dark and washed in Ca 2 þ -free phosphate buffered saline, followed by flow cytometry analysis.
Statistical analysis
Values represent the mean±s.d. from at least three independent experiments. Differences between the experimental groups were analyzed using Student's t-test. A value of Po0.05 was considered statistically significant.
